Focus Merit

ICMR clinical trial finds convalescent plasma therapy against COVID-19 to be ineffective

plasma therapy
  • The trials called PLACID Trials were conducted between 22nd April and 14th July at 39 centres across the country. 
  • There was not any significant difference in mortality rates between those who received convalescent plasma therapy and those in the control group.
Exit mobile version